🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is being done to look at how tucatinib could affect the way othe...
Status
Completed
Location
Covance Clinical Research Unit
Start Date
2018-09-17
Trial ID
NCT03723395
Treatments Being Tested
THIS STUDY IS CURRENTLY RECRUITING PATIENTS WITH ALVEOLAR SOFT PART SARCOMA...
Status
Recruiting
Location
Mayo Clinic Arizona
Start Date
2017-08-15
Trial ID
NCT03016819
This is a Phase 1, open-label, fixed-sequence, 2-part DDI study. Subjects w...
Status
Completed
Location
Site 1
Start Date
2023-01-03
Trial ID
NCT05657613
This study will assess safety, tolerability and pharmacokinetic (PK) of VH3...
Status
Withdrawn
Location
GSK Investigational Site
Start Date
2024-08-02
Trial ID
NCT06533280
The objective of this Open Label Study is to evaluate effects of Rolapitant...
Status
Completed
Location
Parexel Early Phase Unit
Start Date
2015-05
Trial ID
NCT02434861
Treatments Being Tested
The trial is conducted in Europe. The aim of the trial is to investigate if...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2006-05
Trial ID
NCT01518166
Treatments Being Tested
This study will be a single-center, open-label, drug-drug interaction study...
Status
Completed
Location
WCT Early Development
Start Date
2014-01
Trial ID
NCT02055703
Treatments Being Tested
The aim of this trial is to assess the potential key drug-drug interactions...
Status
Completed
Location
Clinical Trial Consultants AB
Start Date
2023-10-23
Trial ID
NCT06118684
Treatments Being Tested
Drug-drug interaction study between Bemnifosbuvir/Ruzasvir and Digoxin or R...
Status
Completed
Location
Atea Study Site
Start Date
2025-04-08
Trial ID
NCT06921941
The main purpose of this study is to assess the safety and tolerability of ...
Status
Recruiting
Location
Fortrea Clinical Research Unit
Start Date
2026-01-15
Trial ID
NCT07339722